PerkinElmer

Biomolecular Discovery

Biotherapeutics drug discovery, much like traditional small molecule drug discovery, starts with validation of the therapeutic target. In many cases validating the target means there is enough data to associate the target to a disease state, and the target can be modulated with a biologic therapeutic.

The early stages of drug discovery are critical and require data-driven breakthroughs, automated workflows to simplify complex analysis to save time and allow scientists to focus in the new biological entity (NBE) discovery and early characterization to enable success during drug development.

Our experts can design your automation needs from nucleic acid isolation to gene expression analysis accoupled with next generation assay platforms allowing for orthogonal hit confirmation using multiple chemistries in a high throughput format, accelerating your path from target ID to lead discovery.

Explore Our Solutions

Biomolecular Target ID & Validation

The early stages of biomolecular discovery comprise of target identification and validation. Molecular characterization and cellular and in vivo imaging technol ...

Learn More

Clone Selection & Development

Clone generation from either hybridoma, phage display or from B cell generates thousands of potential leads. Screening for a primary selection of optimal leads ...

Learn More

Lead Discovery

PerkinElmer Lead Discovery applications enable R&D Scientists to discover actionable insights by seamlessly integrating chemical and biological molecules with a ...

Learn More

Informatics

PerkinElmer’s Informatics solutions empower customers to gain critical insights from data analytics, accelerating informed decisions. Unify data and fast-track ...

Learn More

Nucleic Acid Isolation and PCR Setup

We offer automated solutions for nucleic acid isolation and PCR setup to increase the throughput and reproducibility of PCR workflows for virtually any applicat ...

Learn More

High Content Screening & Analysis

High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric dat ...

Learn More

Immunoassays

Since their introduction in the 1950’s immunoassays have been an integral part of research and drug discovery labs. Immunoassay platforms are commonly used to d ...

Learn More

Nucleic Acid Analysis and Protein Characterization

Utilizing automated microfluidic capillary electrophoresis (micro-CE) technology, our instruments enable the user to simplify the process of traditional gel sep ...

Learn More

Explore Our Instrument Solutions

Microplate Readers

Performance, Versatility, and Reliability for Today’s Laboratory Needs As many of you know, microplate readers are instruments used to detect biological, chemic ...

Learn More

Automated Small Scale Protein Purification

Small scale protein purification presents opportunities for accelerated process development of biotherapeutic molecules. Miniaturization of purification conditi ...

Learn More

Opera Phenix Plus High-Content Screening System

The Opera Phenix® Plus High Content Screening System is the premier confocal solution for today's most demanding high content applications. Drawing on over a de ...

Learn More

LabChip GXII Touch HT Protein Characterization System

The LabChip® GXII Touch™ protein characterization system provides the complete solution for reproducible quantitation, molecular weight sizing and percent purit ...

Learn More

Questions? We're here to help.